• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高钙血症与原发性甲状旁腺功能亢进症。健康筛查中接受噻嗪类药物治疗患者的患病率。

Hypercalcemia and primary hyperparathyroidism. Prevalence in patients receiving thiazides as detected in a health screen.

作者信息

Christensson T, Hellström K, Wengle B

出版信息

Arch Intern Med. 1977 Sep;137(9):1138-42. doi: 10.1001/archinte.137.9.1138.

DOI:10.1001/archinte.137.9.1138
PMID:901082
Abstract

Twenty patients being treated with thiazides were found among 95 subjects (21%) with hyercalcemia verified in repeated determinations in a health screening of 15,903 persons. There were 1,034 patients treated with thiazides in this total health screening. The prevalence of hypercalcemia in the patients treated with thiazides in this total health screening. The prevalence of hypercalcemia in the patients treated with thiazide (1.9%) was considerably higher than the prevalence of hypercalcemia found in the entire health-screened population (0.6%). The thiazide treatment was withdrawn in the 20 hypercalcemic subjects after an examination, and the patients were observed at intervals during a follow-up period of one year. The necks of 14 were explored during or after the follow-up period because of an initial serum calcium level greater than 3.0 mmole/liter or persistent hypercalcemia. Parathyroid adenomas were seen in all patients receiving surgery. Single adenomas predominated in surgical findings. The finding of the present high number of patients with primary hyperparathyroidism may be associated with elevated blood pressure resulting in thiazide treatment after detection.

摘要

在对15903人进行的健康筛查中,经反复测定确诊为高钙血症的95名受试者(21%)中有20名正在接受噻嗪类药物治疗。在这次全面健康筛查中,共有1034名患者接受了噻嗪类药物治疗。在这次全面健康筛查中,接受噻嗪类药物治疗的患者中高钙血症的患病率。接受噻嗪类药物治疗的患者中高钙血症的患病率(1.9%)显著高于在整个接受健康筛查人群中发现的高钙血症患病率(0.6%)。在检查后,这20名高钙血症患者停用了噻嗪类药物治疗,并在一年的随访期内定期对患者进行观察。由于初始血清钙水平大于3.0毫摩尔/升或持续性高钙血症,在随访期间或随访后对14名患者的颈部进行了探查。所有接受手术的患者均发现甲状旁腺腺瘤。手术结果中以单个腺瘤为主。目前发现大量原发性甲状旁腺功能亢进患者可能与血压升高有关,导致在检测后进行噻嗪类药物治疗。

相似文献

1
Hypercalcemia and primary hyperparathyroidism. Prevalence in patients receiving thiazides as detected in a health screen.高钙血症与原发性甲状旁腺功能亢进症。健康筛查中接受噻嗪类药物治疗患者的患病率。
Arch Intern Med. 1977 Sep;137(9):1138-42. doi: 10.1001/archinte.137.9.1138.
2
Electrocardiographic J wave as a result of hypercalcemia aggravated by thiazide diuretics in a case of primary hyperparathyroidism.原发性甲状旁腺功能亢进症患者中,噻嗪类利尿剂加重高钙血症导致的心电图J波。
Jpn Heart J. 2003 Nov;44(6):1033-7. doi: 10.1536/jhj.44.1033.
3
[Nephrolithiasis in hypercalciuria and hyperparathyroidism].高钙尿症和甲状旁腺功能亢进中的肾结石病
MMW Munch Med Wochenschr. 1976 Jun 18;118(25):799-810.
4
Thiazide therapy and severe hypercalcemia in a patient with hyperparathyroidism.一名甲状旁腺功能亢进患者的噻嗪类药物治疗与严重高钙血症
West J Med. 1991 Mar;154(3):338-40.
5
Thiazide-Associated Hypercalcemia: Incidence and Association With Primary Hyperparathyroidism Over Two Decades.噻嗪类药物相关高钙血症:二十年间的发病率及与原发性甲状旁腺功能亢进症的关联
J Clin Endocrinol Metab. 2016 Mar;101(3):1166-73. doi: 10.1210/jc.2015-3964. Epub 2016 Jan 11.
6
Chloride:phosphate ratio with hypercalcemia secondary to thiazide administration.噻嗪类药物使用继发高钙血症时的氯磷比
J Fam Pract. 1983 Jan;16(1):153-4.
7
A case with persistent nephrogenic diabetes insipidus following parathyroidectomy for hyperparathyroidism.一例甲状旁腺功能亢进症患者行甲状旁腺切除术后出现持续性肾性尿崩症的病例。
J Endocrinol Invest. 1988 Dec;11(11):809-12. doi: 10.1007/BF03350231.
8
Incidence and clinical spectrum of thiazide-associated hypercalcemia.噻嗪类药物相关高钙血症的发病率及临床谱
Am J Med. 2007 Oct;120(10):911.e9-15. doi: 10.1016/j.amjmed.2006.07.044. Epub 2007 Apr 16.
9
Failure of thiazide diuretics to increase plasma calcium in mild primary hyperparathyroidism.噻嗪类利尿剂未能增加轻度原发性甲状旁腺功能亢进患者的血钙水平。
Postgrad Med J. 1990 Sep;66(779):714-6. doi: 10.1136/pgmj.66.779.714.
10
[Hypercalcemia and other metabolic disorders during long-term treatment with thiazides].[噻嗪类药物长期治疗期间的高钙血症及其他代谢紊乱]
Tidsskr Nor Laegeforen. 1978 Feb 20;98(5):256-9.

引用本文的文献

1
Calcium Transport in the Kidney and Disease Processes.肾脏中的钙转运和疾病过程。
Front Endocrinol (Lausanne). 2022 Mar 1;12:762130. doi: 10.3389/fendo.2021.762130. eCollection 2021.
2
Thiazide-Associated Hypercalcemia: Incidence and Association With Primary Hyperparathyroidism Over Two Decades.噻嗪类药物相关高钙血症:二十年间的发病率及与原发性甲状旁腺功能亢进症的关联
J Clin Endocrinol Metab. 2016 Mar;101(3):1166-73. doi: 10.1210/jc.2015-3964. Epub 2016 Jan 11.
3
A review of thiazide-induced hyponatraemia.噻嗪类利尿剂引起的低钠血症综述。
Clin Med (Lond). 2011 Oct;11(5):448-51. doi: 10.7861/clinmedicine.11-5-448.
4
Incidence and clinical spectrum of thiazide-associated hypercalcemia.噻嗪类药物相关高钙血症的发病率及临床谱
Am J Med. 2007 Oct;120(10):911.e9-15. doi: 10.1016/j.amjmed.2006.07.044. Epub 2007 Apr 16.
5
ACP Broadsheet no 144: July 1994. The investigation of hypercalcaemia. Association of Clinical Pathologists.《临床病理学家协会会刊》第144期:1994年7月。高钙血症的调查。
J Clin Pathol. 1994 Jul;47(7):579-84. doi: 10.1136/jcp.47.7.579.
6
Mild asymptomatic hyperparathyroidism.轻度无症状甲状旁腺功能亢进症。
Br Med J. 1980 Jul 19;281(6234):174-5.
7
The clinical features of covert diuretic use.隐匿性利尿剂使用的临床特征。
West J Med. 1982 Oct;137(4):331-5.
8
Bedside assessment of hypercalcaemia.
Ir J Med Sci. 1988 Nov;157(11):339-43. doi: 10.1007/BF02948345.
9
Thiazide therapy and severe hypercalcemia in a patient with hyperparathyroidism.一名甲状旁腺功能亢进患者的噻嗪类药物治疗与严重高钙血症
West J Med. 1991 Mar;154(3):338-40.
10
Primary hyperparathyroidism in Austria: results of an 8-year prospective study.奥地利原发性甲状旁腺功能亢进症:一项为期8年的前瞻性研究结果。
World J Surg. 1992 Jul-Aug;16(4):777-82; discussion 782-3. doi: 10.1007/BF02067385.